Healthcare & Medical Devices Global On demand · 24-48h

Global Veterinary Orthotics Prosthetics Market Strategic Research Report

Global Veterinary Orthotics Prosthetics Market Strategic Res…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Veterinary Orthotics Prosthetics Market
$60.042025
9.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Braces, Contracture Bracing, Deformity Braces, Prosthetics, Others

By Application: Veterinary Hospitals, Rehabilitation Centers, Mobile Veterinary Services, Direct to Consumer, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: OrthoPets LLC. (US), Animal Ortho Care (US), Walkin’ Pets / Handicapped Pets (US), My Pet’s Brace (US), K-9 Orthotics & Prosthetics, Inc. (US), Bionic Pets (US), Petsthetics (US), DePuy Synthes Veterinary (US), Movora (US), Johnson and Johnson (US), B. Braun Vet Care (US), Hero Braces (US), Animal Tech (US), Veterinary Inclusive Prosthetics Orthotics (VIP) (US), My Pet’s Pain (US), Bright Animal Orthotics (US), OrthoPets Europe (Germany), CABIOMEDE (Italy), HoviTec (Germany), Veterinary Workshop (UK), Bionic Pets Asia Pacific (Australia), Pawsability (Australia), Animal Ortho Care Asia (South Korea), Vet-Care Orthotics (New Zealand), Orthodesign (Japan), V-Pet Orthopedics (China), Shanghai Medical Instrument Co. (Veterinary Div.) (China), Anhui Bailu Small Animal Orthopedic Instrument Co., Ltd. (Bluesao) (China), Changzhou XC Medico Technology Co., Ltd. (China), Beijing AK Medical Co., Ltd. (China)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 166 pages
Market size 2025
$60.04
Million USD
Forecast CAGR
9.5%
2025-2032
Forecast 2032
$113.3
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Veterinary Orthotics Prosthetics market size is predicted to grow from US$ 60.04 million in 2025 to US$ 113 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.

Veterinary Orthotics Prosthetics refers to custom designed external or implantable devices used to support, align, correct deformities, or replace missing limbs in animals. In 2025,global veterinary orthotics prosthetics production reached approximately 51,150 unit, with an average global market price of around USD 1,200 per unit. A factory gross profit of USD300 per unit with 25% gross margin. A single line full machine capacity production is around 450 unit per line per year. downstream demand is concentrated in veterinary hospital, veterinary orthopedic clinics and veterinary rehabilitation centers. China projected to be a leader in the Asia-Pacific prosthetics and orthotics market, driven by its large, expanding pet population and growing infrastructure for specialized veterinary care. India is an emerging, high-growth market driven by increasing pet humanization, rising awareness of animal welfare, and advancements in 3D printing technology.

Global key Veterinary Orthotics Prosthetics players cover OrthoPets LLC. (US), Animal Ortho Care (US), Walkin’ Pets / Handicapped Pets (US), My Pet’s Brace (US), K-9 Orthotics & Prosthetics, Inc. (US), etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Veterinary Orthotics Prosthetics market?

What factors are driving Veterinary Orthotics Prosthetics market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Veterinary Orthotics Prosthetics market opportunities vary by end market size?

How does Veterinary Orthotics Prosthetics break out by Type, by Application?

This report presents a comprehensive overview of the global Veterinary Orthotics Prosthetics market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Braces
  • Contracture Bracing
  • Deformity Braces
  • Prosthetics
  • Others

Segment by Manufacturing Technology

  • 3D Printing
  • Molding
  • Hybrid
  • Others

Segment by Load Bearing Capacity

  • Small 5-15 Kg
  • Medium 15 -35 Kg
  • Large 35-80 Kg
  • Equine > 250 Kg
  • Others

Segment by Application

  • Veterinary Hospitals
  • Rehabilitation Centers
  • Mobile Veterinary Services
  • Direct to Consumer
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Veterinary Orthotics Prosthetics market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Veterinary Hospitals, Rehabilitation Centers, Mobile Veterinary Services evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Veterinary Orthotics Prosthetics Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$60.04
2025
Forecast
$113.3
2032
CAGR
9.5%
2025–2032
Regions
5
global
Key companies
OrthoPets LLC. (US)Animal Ortho Care (US)Walkin’ Pets / Handicapped Pets (US)My Pet’s Brace (US)K-9 Orthotics & ProstheticsInc. (US)Bionic Pets (US)Petsthetics (US)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
BracesContracture BracingDeformity BracesProstheticsOthers
By Application
Veterinary HospitalsRehabilitation CentersMobile Veterinary ServicesDirect to ConsumerOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Braces
  • 3.1.3 Contracture Bracing
  • 3.1.4 Deformity Braces
  • 3.1.5 Prosthetics
  • 3.1.6 Others
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Veterinary Hospitals
  • 4.1.3 Rehabilitation Centers
  • 4.1.4 Mobile Veterinary Services
  • 4.1.5 Direct to Consumer
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 OrthoPets LLC. (US)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Animal Ortho Care (US)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Walkin’ Pets / Handicapped Pets (US)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 My Pet’s Brace (US)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 K-9 Orthotics & Prosthetics, Inc. (US)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Bionic Pets (US)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Petsthetics (US)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 DePuy Synthes Veterinary (US)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Movora (US)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Johnson and Johnson (US)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 B. Braun Vet Care (US)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Hero Braces (US)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Animal Tech (US)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Veterinary Inclusive Prosthetics Orthotics (VIP) (US)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 My Pet’s Pain (US)
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Bright Animal Orthotics (US)
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 OrthoPets Europe (Germany)
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 CABIOMEDE (Italy)
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 HoviTec (Germany)
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Veterinary Workshop (UK)
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Bionic Pets Asia Pacific (Australia)
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Pawsability (Australia)
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Animal Ortho Care Asia (South Korea)
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Vet-Care Orthotics (New Zealand)
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 Orthodesign (Japan)
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
  • 8.26 V-Pet Orthopedics (China)
  • 8.26.1 Company Overview
  • 8.26.2 Key Products & Segments
  • 8.26.3 Financial Performance (2023–2025)
  • 8.26.4 Business Strategy
  • 8.26.5 SWOT Analysis
  • 8.26.6 Strategic Implications (2026–2032)
  • 8.27 Shanghai Medical Instrument Co. (Veterinary Div.) (China)
  • 8.27.1 Company Overview
  • 8.27.2 Key Products & Segments
  • 8.27.3 Financial Performance (2023–2025)
  • 8.27.4 Business Strategy
  • 8.27.5 SWOT Analysis
  • 8.27.6 Strategic Implications (2026–2032)
  • 8.28 Anhui Bailu Small Animal Orthopedic Instrument Co., Ltd. (Bluesao) (China)
  • 8.28.1 Company Overview
  • 8.28.2 Key Products & Segments
  • 8.28.3 Financial Performance (2023–2025)
  • 8.28.4 Business Strategy
  • 8.28.5 SWOT Analysis
  • 8.28.6 Strategic Implications (2026–2032)
  • 8.29 Changzhou XC Medico Technology Co., Ltd. (China)
  • 8.29.1 Company Overview
  • 8.29.2 Key Products & Segments
  • 8.29.3 Financial Performance (2023–2025)
  • 8.29.4 Business Strategy
  • 8.29.5 SWOT Analysis
  • 8.29.6 Strategic Implications (2026–2032)
  • 8.30 Beijing AK Medical Co., Ltd. (China)
  • 8.30.1 Company Overview
  • 8.30.2 Key Products & Segments
  • 8.30.3 Financial Performance (2023–2025)
  • 8.30.4 Business Strategy
  • 8.30.5 SWOT Analysis
  • 8.30.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Veterinary Orthotics Prosthetics market?
The global Veterinary Orthotics Prosthetics market is estimated at US$ 60.04 million in 2025 (base year) and is projected to reach US$ 113 million by 2032.
How fast is the Veterinary Orthotics Prosthetics market expected to grow?
The market is expected to grow at a CAGR of 9.5% from 2026 to 2032, expanding from US$ 60.04 million in 2025 to US$ 113 million in 2032, roughly 1.9 times its base-year value.
What does the Veterinary Orthotics Prosthetics market cover?
Veterinary Orthotics Prosthetics refers to custom designed external or implantable devices used to support, align, correct deformities, or replace missing limbs in animals. In 2025,global veterinary orthotics prosthetics production reached approximately 51,150 unit, with an average global market price of around USD 1,200 per unit. A factory gross profit of USD300 per unit with 25% gross margin.
How is the Veterinary Orthotics Prosthetics market segmented by type?
By type, the market is segmented into Braces, Contracture Bracing, Deformity Braces, Prosthetics and Others.
What are the key applications of Veterinary Orthotics Prosthetics?
Key applications covered include Veterinary Hospitals, Rehabilitation Centers, Mobile Veterinary Services, Direct to Consumer and Others.
Which companies are profiled in the Veterinary Orthotics Prosthetics market report?
Key players profiled include OrthoPets LLC. (US), Animal Ortho Care (US), Walkin’ Pets / Handicapped Pets (US), My Pet’s Brace (US), K-9 Orthotics & Prosthetics, Inc. (US), Bionic Pets (US), Petsthetics (US) and DePuy Synthes Veterinary (US), among 30 companies covered in total.
What geographies does the Veterinary Orthotics Prosthetics market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Veterinary Orthotics Prosthetics?
What factors are driving Veterinary Orthotics Prosthetics market growth, globally and by region?
Who should buy the Veterinary Orthotics Prosthetics market report?
The report is intended for manufacturers and solution providers, distributors and end users in Veterinary Hospitals, Rehabilitation Centers and Mobile Veterinary Services, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Veterinary Orthotics Prosthetics market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.